Adaptive Biotechnologies eyes expansion to Europe

Adaptive Biotechnologies announced that it is expanding operations to Europe following a big 2020, in which the biotech company signed 35 new lab partnerships in the U.S. and two global contracts with research organizations.

“Adaptive plans to open an international office to enable global expansion,” said CEO and co-founder Chad Robins, “There is a lot of interest in our immunosequencing products from major labs around the world, and we want to improve our ability to capture that business.”

Adaptive has not yet announced where this new European office will be located, but the company is currently hiring for its Seattle headquarters and other offices around the U.S.